HapSense Revisited: The Evidence Behind a Skin-Feel Sensor

In a report dated April 18, 2024, BioSpectrum Asia described HapSense as a patent-pending wearable sensor for measuring how skincare products feel. The announcement was tied to the 10th anniversary of Procter & Gamble Singapore Innovation Centre (SgIC).

Read retrospectively, the report offers a look at an effort to make sensory testing more systematic. Its significance lies in the testing question it raises: how should an instrument’s readings relate to a person’s experience of a product?

Why measuring skin feel was the central goal

According to BioSpectrum Asia, the development involved SgIC and Nanyang Technological University Singapore (NTU Singapore). Singapore’s Agency for Science, Technology and Research (A*STAR) also took part. The report described almost a decade of research-and-development collaboration behind HapSense.

The report’s description of the sensor centered on objective, quantifiable measurements of tactile sensations associated with skincare products. In everyday terms, its stated purpose was to put numbers to aspects of how a product feels.

BioSpectrum Asia contrasted this approach with conventional skin-testing panels. Those panels use product reviewers selected to represent a defined user demographic, depending on the study. The distinction is between a reading produced by an instrument and feedback from people selected for a particular assessment.

The report also said HapSense could allow skincare-product analysis up to 10 times faster than existing skin-testing panels. It described the cost only as “a fraction” of panel testing. Both comparisons were presented as advantages of the testing process.

Beyond skincare, BioSpectrum Asia described haircare and other product categories as potential future applications. It also mentioned fabric care, baby care and feminine care. These were proposed extensions of the technology rather than demonstrated or commercially available uses.

Why the evidence stops short of validation

The available coverage is an announcement report, not a published validation study. Its evidence gaps fall into several distinct areas:

• Technical detail: The report does not describe the sensor’s materials, precise sensing mechanism or body placement. It also does not explain how readings become descriptors such as “smooth” or “sticky.”
• Measurement performance: There is no study sample size, product-comparison result or measure of accuracy and repeatability. No underlying study or peer-reviewed paper is provided.
• Panel comparisons: No benchmark or cost figures are supplied for the efficiency claims. The report does not establish how readings correspond to perceptions across ages, skin types or sensory preferences. It also does not establish that HapSense can replace consumer testing.
• Use and outcomes: There is no commercial launch information or consumer-outcome data in the report.

The scope is also specific: this is a report about tactile product experience, not diagnosis or measures of skin health. It does not assess collagen, aging, hydration or treatment effectiveness.

These gaps do not demonstrate that the technology fails. They mean the announcement alone does not establish its performance. The word “objective” describes the intended measurement approach rather than an independently validated result.

How to read future skincare claims with this distinction in mind

For readers choosing skincare, the practical value lies in reading a claim at the right level. Evidence about a product’s feel should be matched to a claim about feel. A claim about a biological outcome needs evidence that actually measures that outcome.

To see the distinction, consider the questions themselves. “How does this product feel?” is a sensory question. “Does this product change a skin outcome?” is a different research question. The appeal of a new measurement tool should not collapse them into one claim.

That is the same research-reading principle behind Younell’s coverage of matching skincare tests to product claims. It keeps an instrument’s stated purpose separate from a broader promise about visible aging.

When future claims reference tactile sensors, useful questions include:

• What sensation was being assessed?
• How were sensor readings compared with human feedback?
• Does the reported result address feel or another outcome?
• Is the advantage about testing efficiency or about the product experience?

Human feedback also deserves a clear place in the assessment. In a future product claim, the relevant comparison would be whether sensor results and user reports support the same conclusion about feel. That agreement is something to examine rather than assume from the presence of a device.

This is a framework for evaluating evidence, not a reason to change a daily routine. For longer-term claims, our discussion of distinguishing biological measurements from broader aging claims provides another way to keep the outcome and the promise aligned.

Why the next milestone should connect measurements with people

HapSense’s reported development poses a useful research question: how closely do instrument readings match the experiences and preferences that human panels are designed to represent? A useful next step would be published comparisons that show both the sensor measurements and the human assessments.

For now, the April 2024 announcement is best understood as a proposal for more systematic sensory testing. Its lasting relevance rests on the quality of the evidence that connects a measured signal to a meaningful product experience.

Sources

1. Scientists in Singapore develop wearable sensor to measure real skin feel
2. Scientists in Singapore develop wearable sensor to measure real skin feel